Healthcare Financial Management

Every month, hfm shares insights and methods to help organizations cut costs, boost revenue, and handle risks effectively. They offer valuable information tailored for busy CFOs, featuring articles written by leading experts or insights gained from conversations with industry pioneers.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#241781

United States

#50995

Health/Health

#1140

Traffic sources

Monthly visitors

Articles

A new Trump executive order sets the stage for lower 340B payments

1 week ago | hfma.org | Nick Hut

Hospitals can anticipate a regulatory effort to lower the Medicare payments they receive for purchases of Part B drugs through the 340B Drug Pricing Program. President Donald Trump on April 15 signed a wide-ranging executive order on drug costs, and one of the provisions directs HHS to conduct a survey of hospital acquisition costs for covered outpatient drugs.
CMS seeks feedback on applying MAHA guidelines in the U.S. healthcare system

1 week ago | hfma.org | Nick Hut

The Medicare FY26 proposed rule for hospital inpatient payments offers clues as to how the Trump administration will seek to integrate principles of the Make America Healthy Again (MAHA) movement in the healthcare infrastructure. The rule includes a request for information (RFI) on using mandatory hospital quality measurement to foster improvements in nutrition and physical activity. As described by HHS Secretary Robert F.
Medicare’s FY26 inpatient hospital proposed rule includes a restrained payment update

1 week ago | hfma.org | Nick Hut

The Trump administration’s first set of Medicare regulations establishing inpatient hospital payment rates continued what advocates say is a long-term trend in which the annual update falls short. A 3.2% increase in the market basket would be reduced by a 0.8% statutory productivity adjustment, according to the newly released FY26 proposed rule.
Amid market turbulence, hospitals strive for stability in their financials

1 week ago | hfma.org | Nick Hut

Advertisements googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text1' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text2' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text3' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text4' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text5' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text6' ); } );...
2025 healthcare policies timeline

2 weeks ago | hfma.org | Rich Daly |Nick Hut

googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text1' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text2' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text3' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text4' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text5' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text6' ); } ); googletag.cmd.push( function...
How the 340B remedy payments will affect upcoming Medicare Advantage payment rates

2 weeks ago | hfma.org | Nick Hut

Hospital advocates found reason for concern in a narrow aspect of the Medicare Advantage (MA) final payment rate notice for 2026. With health plans lauding the average 5.06%, $25 billion revenue increase they’re projected to reap in the upcoming year, hospitals may wonder about adverse impacts from an applied reduction in CMS’s calculation of the payment rate.
Tariff impact on hospitals may be relatively restrained

2 weeks ago | hfma.org | Nick Hut

Sweeping tariffs announced over the last week by the Trump administration appear to have spared the healthcare industry from immediate consequences in one respect. In his April 2 announcement about the tariffs, President Donald Trump said pharmaceutical ingredients would be exempt, at least for the time being. For now, the exemption removes a worrisome development for the industry, which had been projecting higher costs for generic drugs as a result of the tariffs.
DOGE has plans for HHS. Here's what could happen next.

2 weeks ago | hfma.org | Erika Grotto

googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text1' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text2' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text3' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text4' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text5' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text6' ); } ); googletag.cmd.push( function...
Final 2026 rule for MA, Part D leaves out GLP-1 drug coverage proposal

2 weeks ago | hfma.org | Nick Hut

Advertisements googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text1' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text2' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text3' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text4' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text5' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text6' ); } );...
Questions about Medicaid cuts are unresolved in latest budget reconciliation blueprint

3 weeks ago | hfma.org | Nick Hut

Advertisements googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text1' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text2' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text3' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text4' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text5' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text6' ); } );...